Can You Survive Mesothelioma Long-Term?
Yes, some mesothelioma patients do survive long-term. While mesothelioma has a generally poor prognosis, approximately 10% of patients live five years or more. Long-term survival is more common in patients with early-stage disease, epithelioid cell type, and access to multimodal treatment.
Long-Term Survival Is Possible
While mesothelioma is a serious and aggressive cancer, long-term survival is possible for some patients. Studies of long-term survivors — generally defined as those living five years or more after diagnosis — have identified several characteristics that are associated with extended survival.
These patients tend to be younger, have epithelioid cell type, are diagnosed at earlier stages, and receive multimodal treatment at specialized centers. However, outliers exist in every category, and even patients with less favorable prognostic factors have achieved long-term survival in some cases.
Factors That Contribute to Long-Term Survival
Early detection is one of the most important factors. Patients diagnosed at stage I or II have the best chance of benefiting from curative-intent surgery, which can significantly extend survival when combined with chemotherapy and, in some cases, radiation therapy.
Treatment at experienced mesothelioma centers also matters. Surgeons and oncologists who regularly treat mesothelioma have developed refined techniques and treatment protocols that can improve outcomes. Peritoneal mesothelioma patients treated with cytoreductive surgery and HIPEC at high-volume centers have achieved five-year survival rates exceeding 50%.
Advances in Treatment
Immunotherapy has emerged as a promising treatment for mesothelioma, with the combination of nivolumab and ipilimumab now approved as a first-line treatment option. Some patients have shown durable responses to immunotherapy that extend well beyond what was historically expected with chemotherapy alone.
Clinical trials continue to explore new approaches, including gene therapy, targeted therapies, and novel immunotherapy combinations. Accessing these treatments may require financial resources — pursuing compensation through legal claims can help cover treatment costs and ensure patients have every opportunity to pursue the best available care.
- Long-Term Survival: Approximately 10% of mesothelioma patients live five years or more
- Best Candidates: Early-stage, epithelioid cell type, good overall health
- Peritoneal Patients: 5-year survival rates exceeding 50% with HIPEC at specialized centers
- Immunotherapy: Newer treatments are extending survival for some patients beyond historical averages
Reviewed by: Paul Danziger, J.D. — Texas Bar — 30+ years mesothelioma litigation
Last updated: March 15, 2026
Sources: Annals of Translational Medicine — Long-Term Survivors of Malignant Mesothelioma, Journal of Thoracic Oncology — Characteristics of Long-Term Mesothelioma Survivors, The Lancet Oncology — Immunotherapy in Mesothelioma
Our attorneys have handled mesothelioma cases for over 30 years. We can evaluate your situation, explain every option available to you, and answer your questions — all at no cost and with no obligation.
Request a Free Consultation
Your information is confidential and protected. We typically respond within 24 hours.
Call 1-800-400-1805 for immediate help.